Lithium is a mood stabilizer produced by Alhavi Pharmaceutical.
It is primarily used in the treatment and prevention of bipolar disorder (manic-depressive illness) by regulating neurotransmitter activity in the brain and reducing extreme mood swings.
Lithium also decreases the risk of suicide in patients with bipolar disorder and can enhance the effects of antidepressants in treatment-resistant depression.
Therapy requires close medical supervision with regular monitoring of blood lithium levels and potential side effects.
Lithium
Dosage form: Tablet
Lithium is indicated for:
• Treatment and prevention of manic episodes in bipolar disorder
• Reduction of suicide risk in patients with bipolar disorder
• Augmentation of antidepressant therapy in treatment-resistant depression
Lithium stabilizes mood by influencing neurotransmitter activity and neuronal signaling in the brain.
Continuous medical monitoring is required due to its narrow therapeutic range.
• Dosage is individualized based on blood lithium levels (therapeutic range: 0.6–1.2 mEq/L)
• Take with adequate water and divide doses throughout the day
• Maintain a consistent intake of dietary salt and fluids
• Avoid sudden changes in sodium or fluid consumption
• Regularly monitor lithium blood levels and kidney/thyroid function as advised by your physician